![ECOG-ACRIN logo[19516]275×75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
April 24, 2026
A preview of the upcoming Spring Group Meeting, a recap of AACR 2026, and an update on the current state of the NCI's cancer research efforts
April 24, 2026
This phase 3 clinical trial is comparing aromatase inhibitors and ribociclib, with and without chemotherapy, to prevent recurrence
April 24, 2026
This phase 2 trial is evaluating pembrolizumab immunotherapy after surgery in patients with recurrent or second primary head and neck cancer with high-risk features
April 24, 2026
The latest clinical trial findings in breast cancer, cancer control and survivorship, health equity, leukemia, melanoma, and NCI-MATCH
April 24, 2026
Timely information about research presented at medical meetings, recognition of research leaders, and more